ABCB1 and cancer: Metformin reduces the expression of the P-glycoprotein (P-gp) encoded by multidrug resistance1 (MDR1), and, via this action, it blocks drug efflux from cancer cells, allowing metformin to be used as an adjuvant relative to classical chemotherapy [164].